SCHEMBL216280

SCHEMBL216280

C(OCC1CO1)C1CO1.[PoH2].[PoH2]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.65
ALDH1A1 P00352 10/20 0.56
MAPK1 P28482 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.54
TDP1 Q9NUW8 3/20 0.50
TP53 P04637 5/20 0.39
CYP3A4 P08684 2/20 0.39
HIF1A Q16665 2/20 0.39
GLA P06280 1/20 0.37
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
KMT2A Q03164 1/20 0.34
PPARG P37231 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
CHRM2 P08172 1/20 0.32
CHRM5 P08912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2933673 0.97
SCHEMBL15245 0.97
SCHEMBL4623846 0.97
SCHEMBL4895623 0.97 TSHR (0.68) TSHRALDH1A1MAPK1SMN1; SMN2TDP1
SCHEMBL2933671 0.97
Water SCHEMBL462214 0.93 TSHR (0.65) TSHRALDH1A1MAPK1SMN1; SMN2TDP1
Bromide SCHEMBL10338450 0.93 TSHR (0.65) TSHRALDH1A1MAPK1SMN1; SMN2TDP1
SCHEMBL4450781 0.93 TSHR (0.65) TSHRALDH1A1MAPK1SMN1; SMN2TDP1
Water SCHEMBL3652389 0.93 TSHR (0.65) TSHRALDH1A1MAPK1SMN1; SMN2TDP1
Methane SCHEMBL292683 0.93 TSHR (0.65) TSHRALDH1A1MAPK1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1172492-A None JP disclosed
US-9006316-B2 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2015-04-14 US disclosed
US-8912113-B2 Compositions of a metal amidine complex and second compound, coating compositions comprising same KING INDUSTRIES, INC. (US) 2014-12-16 US disclosed
EP-2683767-A1 COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME KING INDUSTRIES, INC. (US) 2014-01-15 EP disclosed
WO-2012122098-A1 COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME KING INDUSTRIES, INC. (US) 2012-09-13 WO disclosed
US-20120225982-A1 COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME KING INDUSTRIES, INC. 2012-09-06 US disclosed
US-20120070569-A1 ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS KING INDUSTRIES, INC. (US) 2012-03-22 US disclosed
US-8088846-B2 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2012-01-03 US disclosed
US-7485729-B2 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes KING INDUSTRIES, INC. (US) 2009-02-03 US disclosed
US-20090011124-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes HSIEH BING 2009-01-08 US disclosed
US-20060036007-A1 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2006-02-16 US disclosed
EP-1235646-B1 METAL SALTS OF PHOSPHORIC ACID ESTERS AS CROSS LINKING CATALYSTS KING INDUSTRIES INC (US) 2004-06-16 EP disclosed
EP-1235646-A4 METAL SALTS OF PHOSPHORIC ACID ESTERS AS CROSS LINKING CATALYSTS KING INDUSTRIES INC (US) 2003-02-05 EP disclosed
EP-1235646-A1 METAL SALTS OF PHOSPHORIC ACID ESTERS AS CROSS LINKING CATALYSTS KING INDUSTRIES, INC. (US) 2002-09-04 EP disclosed
US-6335304-B1 COATING FORMULATION THAT IS STABLE AT ROOM TEMPERATURE, HUMIDITY RESISTANT AND NON-YELLOWING KING INDUSTRIES, INC 2002-01-01 US disclosed
WO-2001037991-A1 METAL SALTS OF PHOSPHORIC ACID ESTERS AS CROSS LINKING CATALYSTS KING INDUSTRIES, INC. (US) 2001-05-31 WO disclosed
EP-0595530-A1 Epoxide resins derived from polycyclic phenols CIBA-GEIGY AG (CH) 1994-05-04 EP disclosed
JP-H01172492-A CONTAMINATION INHIBITOR FOR PETROLEUM REFINING KURITA WATER IND LTD 1989-07-07 JP disclosed
US-4446307-A Tire cord adhesive composition WILMINGTON CHEMICAL CORPORATION (US) 1984-05-01 US disclosed
US-4419468-A POLYCARBOXYLIC ACID, DISCOLORATION INHIBITION PPG INDUSTRIES, INC. (US) 1983-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070569-A1 ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS UROD, AOC1, AOC2 TSHR 4810/4885ALDH1A1 1455/4885MAPK1 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.